A Look At The Prostrate Cancer Treatment Market
moreView todays social media effects on ISRView the latest stocks trending across Twitter. Click to view dashboardSee who IsoRay is hiring next, click here to view […]
ISR
IsoRay on Display at the American Brachytherapy Society (ABS) Convention Featuring Its Cesium-131 Cancer Fighting Portfolio
[Marketwired] – IsoRay Inc. , a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced it will host a booth at the Annual Meeting of the American Brachytherapy … moreView todays social media effects on ISRView the latest stocks trending across Twitter. Click to view dashboardSee who IsoRay is hiring next, click here to view […]
ISORAY, INC. Files SEC form 8-K/A, Entry into a Material Definitive Agreement
moreView todays social media effects on ISRView the latest stocks trending across Twitter. Click to view dashboardSee who IsoRay is hiring next, click here to view […]
ISORAY, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
moreView todays social media effects on ISRView the latest stocks trending across Twitter. Click to view dashboardSee who IsoRay is hiring next, click here to view […]
IsoRay says policy is not to comment on unusual market activity
moreView todays social media effects on ISRView the latest stocks trending across Twitter. Click to view dashboardSee who IsoRay is hiring next, click here to view […]
IsoRay, Inc. States Its Policy Not to Comment on Unusual Market Activity
[PR Newswire] – RICHLAND, Wash., Feb. 27, 2013 /PRNewswire/ — IsoRay, Inc. (NYSE MKT: ISR) (IsoRay or the Company), a medical technology company and innovator in seed brachytherapy and medical … moreView todays social media effects on ISRView the latest stocks trending across Twitter. Click to view dashboardSee who IsoRay is hiring next, click here to view […]
Glioblastoma and Metastatic Brain Cancer Treatments were Performed on Multiple Patients at the University Hospital of Rostock in Germany
[at noodls] – FOR IMMEDIATE RELEASE FIRST INTERNATIONAL BRAIN CANCER TREATMENTS PERFORMED UTILIZING ISORAY’S GLIASITE RADIATION THERAPY SYSTEM Glioblastoma and Metastatic Brain Cancer Treatments Were Performed On Multiple … moreView todays social media effects on ISRView the latest stocks trending across Twitter. Click to view dashboardSee who IsoRay is hiring next, click here to view […]
IsoRay, Inc. Reports Second Quarter Results 14% of Revenue Attributed to Non Prostate Cases Fueled by New Cancer Facilities
[at noodls] – FOR IMMEDIATE RELEASE ISORAY, INC. REPORTS SECOND QUARTER RESULTS 14% Of Revenue Attributed To Non Prostate Cases Fueled By New Cancer Facilities RICHLAND, Washington (February 14, 2013) – IsoRay, Inc. … moreView todays social media effects on ISRView the latest stocks trending across Twitter. Click to view dashboardSee who IsoRay is hiring next, click here to view […]
IsoRay’s Cesium-131 Seeds Proves Successful for Brain Cancer Treatment as Presented by Weill Cornell and Barrow Neurological to the Society of Neuro-Oncology
[at noodls] – FOR IMMEDIATE RELEASE ISORAY’S CESIUM-131 SEEDS PROVES SUCCESSFUL FOR BRAIN CANCER TREATMENT AS PRESENTED BY WEILL CORNELL AND BARROW NEUROLOGICAL TO THE SOCIETY OF NEURO-ONCOLOGY Sutured Seeds and Seed … moreView todays social media effects on ISRView the latest stocks trending across Twitter. Click to view dashboardSee who IsoRay is hiring next, click here to view […]
IsoRay, Inc. Reports Fiscal Year 2012 Results Non Prostate Revenues Up 75% To 14% of Total Revenues
[at noodls] – FOR IMMEDIATE RELEASE ISORAY, INC. REPORTS FISCAL YEAR 2012 RESULTS Non Prostate Revenues Up 75% To 14% of Total Revenues RICHLAND, Washington (September 28, 2012) – IsoRay Inc. (AMEX: ISR), a medical … moreView todays social media effects on ISRView the latest stocks trending across Twitter. Click to view dashboard […]
